Child's Nervous System

, 22:475

Monitoring the growth effect of xenotransplanted human medulloblastoma in an immunocompromised mouse model using in vitro and ex vivo green fluorescent protein imaging

  • Shih-Hwa Chiou
  • Chung-Lan Kao
  • Han-Tso Lin
  • Wen-Ser Tseng
  • Ren-Shyan Liu
  • Chen-Fun Chung
  • Hung-Hai Ku
  • Ching-Po Lin
  • Tai-Tong Wong
Original Paper

Abstract

Introduction

Medulloblastoma (MB) is one of the most common malignant brain tumors in children. It is a radiosensitive tumor. At 5 years after radical surgical excision and craniospinal axis irradiation, the tumor-free survival rate is from 50 to 70% [Halperin EC, Constine LS, Tarbell NJ, Kun LE. Pediatric radiation oncology (2005)].

Case report

In this study, we established xenotransplanted human MB (hMB) cells — isochromosome 17q — in a severe combined immunodeficiency (SCID) mouse model. We further transduced green fluorescent protein (GFP) into hMB cells to evaluate these hMB cells grafted in SCID mice.

Results

The result of an ex vivo GFP imaging system showed that a small lesion of the third-week-hMB-transplanted graft presented “green” signals with a clear tumor margin before any tumor-related symptoms were noted. We also demonstrated that the tumor progression could be monitored by GFP imaging for up to 12 weeks post-transplantation.

Conclusions

This novel approach of GFP imaging assessment provides more accurate information of tumor status for experimental brain tumor studies. Because MB is sensitive to radiation and also response to chemotherapy, this SCID mouse model will be helpful for preclinical studies in the future.

Keywords

Medulloblastoma Green fluorescent protein imaging SCID mouse model 

References

  1. 1.
    Halperin EC, Constine LS, Tarbell NJ, Kun LE (2005) Pediatric radiation oncology. Lippincott Williams & Wilkins, Philadelphia, pp 89–107Google Scholar
  2. 2.
    McNeil DE, Cote TR, Clegg L, Rorke LB (2002) Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Med Pediatr Oncol 39:190–194PubMedCrossRefGoogle Scholar
  3. 3.
    Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM (1999) Metastasis stage, adjunvant treatment, and residual tumor are prognostic factors for medulloblastoma in children. J Clin Oncol 17:832–845PubMedGoogle Scholar
  4. 4.
    Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978–986PubMedCrossRefGoogle Scholar
  5. 5.
    Rice JM (2004) Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models. Toxicol Appl Pharm 199:175–191CrossRefGoogle Scholar
  6. 6.
    Dyer MA (2004) Mouse models of childhood cancer of the nervous system. J Clin Pathol 57:561–576PubMedCrossRefGoogle Scholar
  7. 7.
    Sterling-Levis K, White L (2003) The role of xenografting in pediatric brain tumor research with specific emphasis on medulloblastoma/primitive neuroectodermal tumors of childhood. In Vivo 17:329–342PubMedGoogle Scholar
  8. 8.
    White L, Sterling-Levis K, Kees UR (2001) Medulloblastoma/primitive neuroectodermal tumor studied as a Matrigel enhanced subcutaneous xenograft model. J Clin Neurosci 8:151–156PubMedCrossRefGoogle Scholar
  9. 9.
    Huang P, Allam A, Taghian A, Freeman J, Duffy M (1995) Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice. J Neurosurg 83:308–315PubMedGoogle Scholar
  10. 10.
    Kao CL, Chiou SH, Chen YJ, Singh S, Lin HT (2005) Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol 18:769–778PubMedCrossRefGoogle Scholar
  11. 11.
    Chen YJ, Chen PJ, Lee MC, Yeh SH, Hsu MT, Lin CH (2002) Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosomes Cancer 35:138–143PubMedCrossRefGoogle Scholar
  12. 12.
    Peng H, Chen ST, Wergedal JE, Polo JM, Yee JK (2001) Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther 4:95–104PubMedCrossRefGoogle Scholar
  13. 13.
    Vachon P, Girard C, Theoret Y (2004) Effects of basic fibroblastic growth factor on the growth of human medulloblastoma xenograft. J Neurooncol 67:139–146PubMedCrossRefGoogle Scholar
  14. 14.
    Ho DM, Hsu CY, Chiang H (2002) Histopathologic grading of medulloblastomas. Cancer 95:2577–2578PubMedCrossRefGoogle Scholar
  15. 15.
    Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL (2004) Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-CGH. J Neurosurg 100:187–193PubMedGoogle Scholar
  16. 16.
    Saunders DE, Hayward RD, Phipps KP, Chong WK, Wade AM (2003) Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long? J Neurosurg 99:280–286PubMedCrossRefGoogle Scholar
  17. 17.
    Wetmore C, Eberhart DE, Curran T (2001) Loss of p53 but not accelerate medulloblastoma in mice heterozygous for patched. Cancer Res 61:513–516PubMedGoogle Scholar
  18. 18.
    Pang JC, Chang Q, Chung YF, Teo JG, Poon WS (2005) Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol 36:36–43PubMedCrossRefGoogle Scholar
  19. 19.
    Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C (2004) RENKCTD11 is a suppressor of hedgehog signaling and is deleted in human medulloblastoma. Proc Natl Acad Sci USA 101:10833–10838PubMedCrossRefGoogle Scholar
  20. 20.
    Pinte S, Stankovic-Valentin N, Deltour S, Rood BR, Guerardel C, Leprince D (2004) The tumor suppressor gene HIC1 is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J Biol Chem 279:38313–38324PubMedCrossRefGoogle Scholar
  21. 21.
    MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29:143–152PubMedCrossRefGoogle Scholar
  22. 22.
    Gilbertson RJ, Clifford SC (2003) PDGFRB is overexpressed in metastatic medulloblastoma. Nat Genet 35:197–198PubMedCrossRefGoogle Scholar
  23. 23.
    Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY (1995) Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 20:448–455PubMedCrossRefGoogle Scholar
  24. 24.
    Niwa H, Inouye S, Hirano T, Matsuno T, Kojima S (1996) Chemical nature of the light emitter of the Aequorea green fluorescent protein. Proc Natl Acad Sci USA 93:13617–13622PubMedCrossRefGoogle Scholar
  25. 25.
    Hanson MR, Kohler RH (2001) GFP imaging: methodology and application to investigate cellular compartmentation in plants. J Exp Bot 52:529–539PubMedCrossRefGoogle Scholar
  26. 26.
    Alba FJ, Bermudez A, Daban JR (2001) Green-light transilluminator for the detection without photodamage of proteins and DNA labeled with different fluorescent dyes. Electrophoresis 22:399–403PubMedCrossRefGoogle Scholar
  27. 27.
    Jing D, Agnew J, Patton WF, Hendrickson J, Beechem JM (2003) A sensitive two-color electrophoretic mobility shift assay for detecting both nucleic acids and protein in gels. Proteomics 3:1172–1180PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Shih-Hwa Chiou
    • 1
    • 7
  • Chung-Lan Kao
    • 2
  • Han-Tso Lin
    • 1
    • 5
  • Wen-Ser Tseng
    • 3
  • Ren-Shyan Liu
    • 4
  • Chen-Fun Chung
    • 5
  • Hung-Hai Ku
    • 5
  • Ching-Po Lin
    • 6
  • Tai-Tong Wong
    • 3
  1. 1.Department of Education and ResearchThe Neurological InstituteTaiwanRepublic of China
  2. 2.Department of Physical Medicine & RehabilitationThe Neurological InstituteTaiwanRepublic of China
  3. 3.Division of Pediatric Neurosurgery, The Neurological InstituteTaipei Veterans General Hospital and National Yang-Ming UniversityTaiwanRepublic of China
  4. 4.Department of Nuclear MedicineTaipei Veterans General Hospital and National Yang-Ming UniversityTaiwanRepublic of China
  5. 5.Institute of Anatomy and Cell BiologyNational Yang-Ming UniversityTaiwanRepublic of China
  6. 6.Institute of NeuroscienceNational Yang-Ming UniversityTaiwanRepublic of China
  7. 7.Institute of Clinical MedicineNational Yang-Ming UniversityTaiwanRepublic of China

Personalised recommendations